2014
DOI: 10.1136/jmedgenet-2014-102287
|View full text |Cite
|
Sign up to set email alerts
|

A homozygous nonsense CEP250 mutation combined with a heterozygous nonsense C2orf71 mutation is associated with atypical Usher syndrome

Abstract: A homozygous nonsense CEP250 mutation, in combination with a heterozygous C2orf71 nonsense mutation, causes an atypical form of USH, characterised by early-onset SNHL and a relatively mild RP. The severe retinal involvement in the double homozygotes indicates an additive effect caused by nonsense mutations in genes encoding ciliary proteins.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
73
0
6

Year Published

2015
2015
2022
2022

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 80 publications
(83 citation statements)
references
References 39 publications
4
73
0
6
Order By: Relevance
“…Next, we designed morpholino oligonucleotides (MO) for both genes: a splice blocker for rp1l1 , and a translational blocker for c2orf71l due to the lack of useable designs for a splice blocker. As a first test, we evaluated the impact of suppression of each of the two genes on early gastrulation; both genes have been shown to be relevant to ciliary function, 79 perturbation of which induces convergent extension (CE) defects in mid-somitic embryos. 10,11 Consistent with this expectation, suppression of each of rp1l1 and c2orf71l induced CE defects; embryos with an expansion of the “gap angle” (>45°) were considered affected and were plotted as such (Figs.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Next, we designed morpholino oligonucleotides (MO) for both genes: a splice blocker for rp1l1 , and a translational blocker for c2orf71l due to the lack of useable designs for a splice blocker. As a first test, we evaluated the impact of suppression of each of the two genes on early gastrulation; both genes have been shown to be relevant to ciliary function, 79 perturbation of which induces convergent extension (CE) defects in mid-somitic embryos. 10,11 Consistent with this expectation, suppression of each of rp1l1 and c2orf71l induced CE defects; embryos with an expansion of the “gap angle” (>45°) were considered affected and were plotted as such (Figs.…”
Section: Resultsmentioning
confidence: 99%
“…28 Interestingly, a heterozygous C2orf71 null allele in combination with a homozygous nonsense mutation in CEP250 was associated with atypical Usher syndrome, characterized by early-onset sensorineural hearing loss and a relatively mild form of RP. 9 In a double homozygote of these variants the retina was more severely affected suggesting an additive effect in these ciliary proteins.…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, some evidence have shown the potential involvement of CEP78 in retinal and hearing abnormalities: CEP78 was identified to interact with cilia protein CEP250,30 and the latter is a known Usher syndrome protein 31. In another study, researchers tried identifying crucial genes which show significantly altered expression in cochlea after noise-induced hearing loss and CEP78 was among the 15 genes with more than fivefold upregulation.…”
Section: Discussionmentioning
confidence: 99%
“…To date, sixteen loci have been associated with USH: nine are involved in USH1, three in USH2, two in USH3 and two not specified (Table 1) [9, 23–27]. From these loci, thirteen genes have been identified.…”
Section: Genes and Loci Identified In Ush Patientsmentioning
confidence: 99%
“…CLRN1 (Clarin-1) and HARS (histidyl-tRNA synthetase) are the USH3 genes [25, 4042]. Furthermore, PDZD7 (PDZ domain containing 7) was recently discovered as an USH modifier and digenic USH contributor gene [26], and CEP250 as an atypical USH gene [27]. Among these genes, HARS is debatable as an USH3 gene, because patients carrying mutations in this gene develop episodic psychosis as well as progressive hearing loss and RP [25], which could be clinical symptoms of other rare syndromes.…”
Section: Genes and Loci Identified In Ush Patientsmentioning
confidence: 99%